Joseph Bilgimol Chumappumkal, Sekayan Tro, Falah Nicca, Barnes Richard F W, Flood Veronica, De Pablo-Moreno Juan A, von Drygalski Annette
Department of Medicine, Division of Hematology/Oncology, University of California San Diego, La Jolla, California, USA.
Versiti Blood Research Institute, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Res Pract Thromb Haemost. 2024 Aug 8;8(6):102543. doi: 10.1016/j.rpth.2024.102543. eCollection 2024 Aug.
Clinical evidence suggests that anemia exacerbates traumatic bleeding and worsens outcomes.
To study the influence of iron deficiency anemia on traumatic bleeding, coagulopathy, and mortality.
C57BL/6J mice received an iron-deficient diet (8 weeks; ±1 mg intraperitoneal iron dextran 2 weeks before trauma). Control mice received a normal diet. Iron deficiency anemia was confirmed by hematocrit, red cell indices, and liver iron. Mice received saline or tranexamic acid (TXA; 10 mg/kg) just before liver laceration. Blood loss, coagulopathy (activated partial thromboplastin time, factor [F]II, FV, FVIII, FX, and fibrinogen), D-dimer, thrombin-antithrombin complexes, and plasmin-alpha-2-antiplasmin complexes were analyzed at 15 and 60 minutes, and a cytokine panel was performed at 60 minutes and 6 hours after trauma. Survival was monitored for 7 days.
Compared with nonanemic mice, anemic mice had lower hematocrit and hepatic iron content. Anemic mice experienced higher blood loss compared with nonanemic mice, which was reduced by TXA. Both groups developed traumatic coagulopathy characterized by activated partial thromboplastin time prolongation, thrombin-antithrombin complex formation, and depletion of FV, FVIII, and fibrinogen. TXA corrected the coagulopathy. However, plasmin-alpha-2-antiplasmin complex formation and D-dimers, markers of fibrinolysis, were higher in anemic mice and were not corrected by TXA. Seven-day survival was low in anemic mice, and rescued by TXA, but high in nonanemic mice without additional improvement by TXA. Among cytokines, only interleukin-6 increased, which was prevented by TXA most notably in anemic mice.
These observations provide first and critical proof-of-principle evidence that anemia accelerates traumatic bleeding and increases mortality, which could be rescued by anemia correction (parenteral iron) or periprocedural TXA.
临床证据表明贫血会加剧创伤性出血并使预后恶化。
研究缺铁性贫血对创伤性出血、凝血病和死亡率的影响。
C57BL/6J小鼠接受缺铁饮食(8周);在创伤前2周腹腔注射±1毫克右旋糖酐铁。对照小鼠接受正常饮食。通过血细胞比容、红细胞指数和肝脏铁含量确认缺铁性贫血。在肝脏撕裂伤前,小鼠接受生理盐水或氨甲环酸(TXA;10毫克/千克)。在15分钟和60分钟时分析失血量、凝血病(活化部分凝血活酶时间、因子[F]II、FV、FVIII、FX和纤维蛋白原)、D - 二聚体、凝血酶 - 抗凝血酶复合物和纤溶酶 - α2 - 抗纤溶酶复合物,并在创伤后60分钟和6小时进行细胞因子检测。监测7天的生存率。
与非贫血小鼠相比,贫血小鼠的血细胞比容和肝脏铁含量较低。与非贫血小鼠相比,贫血小鼠的失血量更高,TXA可减少失血量。两组均出现以活化部分凝血活酶时间延长、凝血酶 - 抗凝血酶复合物形成以及FV、FVIII和纤维蛋白原消耗为特征的创伤性凝血病。TXA纠正了凝血病。然而,纤溶酶 - α2 - 抗纤溶酶复合物形成和D - 二聚体(纤溶标记物)在贫血小鼠中更高,且未被TXA纠正。贫血小鼠7天生存率低,TXA可挽救,但非贫血小鼠生存率高,TXA未带来进一步改善。在细胞因子中,只有白细胞介素 - 6增加,TXA最显著地在贫血小鼠中阻止了其增加。
这些观察提供了首个关键的原理性证据,即贫血会加速创伤性出血并增加死亡率,可通过纠正贫血(胃肠外补铁)或围手术期使用TXA来挽救。